Please login or register first to view this content.
Endocrine Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Dapagliflozin Under Review for Chronic Kidney Disease
Experts Weigh In on the Best Diets for 2021
FDA Approves First Generic Version of Glucagon Emergency Kit
Tepezza Supply Shortage Expected Soon
Metformin Use May Reduce Mortality in Women With COVID-19
Tirzepatide Cuts HbA1c, Body Weight in T2D Study
No Significant Difference Between Sitagliptin, Placebo in Pediatric T2D Trials
Alkindi Sprinkle Now Available for Pediatric Adrenocortical Insufficiency
Finerenone NDA Submitted for Diabetic Kidney Disease
Generic Version of Tirosint Now Available
Teplizumab BLA for T1D Prevention Submitted
Gimoti Nasal Spray Now Available for Diabetic Gastroparesis
Higher Levothyroxine Doses Linked to Afib in Older Patients
Insulin Pens Should Be Dispensed in Original Packaging, Says FDA
Ertugliflozin Noninferior for CV Outcomes in T2DM With ASCVD
Once-Weekly Somatrogon Reduces Treatment Burden in Children With GHD
Dapagliflozin Gets Breakthrough Therapy Status for CKD Indication
Is Generic Levothyroxine as Effective as Brand Name for Mild Thyroid Dysfunction?